Graft Polymer (UK) PLC Result of AGM (4404H)
July 27 2023 - 6:54AM
UK Regulatory
TIDMGPL
RNS Number : 4404H
Graft Polymer (UK) PLC
27 July 2023
27 July 2023
Graft Polymer (UK) PLC
("Graft Polymer" or the "Company")
Result of AGM
Graft Polymer, (LSE:GPL) the specialty chemicals company
offering modified polymer solutions for refiners, compounders and
processors, announces that at the Company's annual general meeting
(the "AGM"),held earlier today all resolutions were duly
passed.
Commenting, Roby Zomer, Non Executive Chairman said ' With the
commissioning of the new facility and the recent addition of
additional licensed distributors the Group is in a very strong
position to increase commercial momentum and win customer mandates.
We look forward to the remainder of the year with increased
confidence.'
ENDS
For further information, visit www.graftpolymer.com ,follow on
Twitter @PolymerLtd or contact:
Graft Polymer (UK) Plc
Roby Zomer, Non Executive Chairman Via Flagstaff
Yifat Steur, CFO and Executive Chairman
Turner Pope Investments Tel:+44 (0) 20 3657 0050
James Pope
Andy Thacker
Flagstaff Strategic and Investor Communications Tel + 44 (0) 207 129 1474
Tim Thompson graftpolymer@flagstaffcomms.com
Mark Edwards
Alison Allfrey
Anna Probert
About Graft Polymer
Graft Polymer is a London Stock Exchange listed company (GPL.L)
with a cutting-edge, cash-flow positive, research and development
(R&D) and manufacturing facility based in Slovenia which has
already introduced more than 50 products to the market. The core
business of the Group comprises polymer modification and drug
delivery system developments. The Group has developed a proprietary
set of polymer modification technologies which uses recycled raw
materials and a closed loop system to reduce waste. Graft Polymer's
technology can improve existing products and processing
methodologies by enhancing performance, simplifying manufacturing,
reducing material consumption, widening the choice of feedstocks,
and reducing costs.
Graft Polymer has three divisions: the first division focusses
on polymer modification; the second is GraftBio which develops IP
for Bio/Pharma applications (including a drug delivery system to
support and provide solutions to the market, which had been heavily
impacted by the COVID-19 pandemic); and the third is the Group's
food supplement division. A significant milestone was reached in
May 2022 when the Slovenian manufacturing facility was granted a
Hazard Analysis and Critical Control Point (HACCP) Certificate. The
HACCP Certificate allows it to enter the lucrative
Business-to-Consumer market and commercialise its IP for bio/pharma
applications, developing active pharmaceutical ingredients and drug
delivery platforms for use in the food supplement market, thereby
introducing a further revenue stream to its business.
Environment, Social and Governance is at the forefront of the
Group's strategy and the facility in Slovenia has been granted ISO
14001 accreditation in recognition of the environmental management
systems in place to reduce waste. Graft Polymer only uses REACH and
ROHS certificated raw materials instead of toxic raw materials, and
its extensive R&D programme has also developed specialised
recycling polymer additives which increases the strength of
recycled blends and plastic products whilst also reducing plastic
waste by between 40 and 50 per cent.
Graft Polymer is debt free.
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGUBVRROSUBUAR
(END) Dow Jones Newswires
July 27, 2023 06:54 ET (10:54 GMT)
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Sep 2023 to Sep 2024